Drawing for 3DBIOLABS

USPTO serial 88174670

3DBIOLABS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BELL, MARLENE D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with 3DBIOLABS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sharon R Smith

Sharon R Smith MORGAN, LEWIS & BOCKIUS LLPONE MARKET STREET, SPEAR STREET TOWERSAN FRANCISCO, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for scientific and medical research use; artificial organs incorporating live human cells, namely, live tissue for scientific and medical research and use; Pharmaceutical preparations, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for scientific and medical research useACTIVE—
005Pharmaceutical preparations, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for medical purposes; biological implants, namely, live tissue intended for subsequent implantationACTIVE—
010Medical device, namely, surgical devices that facilitate the implantation of artificial organsACTIVE—
042Medical research and development in the field of tissue and cell fabricationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 21, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 20, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2022EX5GSOU EXTENSION 5 GRANTED—
Jul 27, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 11, 2022EXT5SOU EXTENSION 5 FILED—
Jul 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 10, 2022EX4GSOU EXTENSION 4 GRANTED—
Jan 10, 2022EXT4SOU EXTENSION 4 FILED—
Jan 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 29, 2021EX3GSOU EXTENSION 3 GRANTED—
Jun 29, 2021EXT3SOU EXTENSION 3 FILED—
Jun 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2021EX2GSOU EXTENSION 2 GRANTED—
Jan 12, 2021EXT2SOU EXTENSION 2 FILED—
Jan 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 13, 2020EX1GSOU EXTENSION 1 GRANTED—
Jul 13, 2020EXT1SOU EXTENSION 1 FILED—
Jul 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 8, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 8, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 8, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 8, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2019CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jul 1, 2019ALIEASSIGNED TO LIE—
Jun 29, 2019GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 29, 2019GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 29, 2019CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Feb 12, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2019DOCKASSIGNED TO EXAMINER—
Nov 15, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance